News

SHERIDAN, WYOMING – May 11, 2025 – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has announced unanimous shareholder approval of all proposals presented at its 2025 Annual General Meeting (AGM), reinforcing the company’s commitment to strong corporate governance, strategic continuity, and long-term value creation.

The AGM resolutions, which include key board appointments and financial authorizations, position Philips to maintain momentum in executing its innovation-driven strategy across global health systems. Among the most notable outcomes were the re-appointments of seasoned Supervisory Board members Ms. Indra Nooyi and Ms. Chua Sock Koong, as well as the appointment of Mr. Bob White, a well-respected health technology executive, to the Supervisory Board.

Strengthening Strategic Leadership

SHERIDAN, WYOMING - May 11, 2025 - KaVo, a global leader in dental equipment innovation, is spotlighting its ELECTROmatic Premium motor system with a flash promotion running through May 30, 2025-offering dental professionals a timely opportunity to elevate their operatory performance with one of the most advanced electric handpiece systems on the market.

As dental practices seek greater operational efficiency, improved precision, and dependable tools that can handle daily clinical demands, the KaVo ELECTROmatic Premium has emerged as a strategic solution. Designed to integrate seamlessly into modern workflows, the system provides unmatched torque, speed, and versatility, redefining what dental professionals can expect from their most-used instrument: the handpiece.

Power, Precision, and Performance for Restorative and Endodontic Dentistry

SHERIDAN, WYOMING – May 11, 2025 – Saudi Arabia has taken a significant step toward bolstering its advanced manufacturing capabilities with the signing of a Memorandum of Understanding (MoU) with global packaging solutions leader Sidel. The agreement, signed in Paris during the official visit of the Saudi Minister of Industry and Mineral Resources, aims to explore establishing Sidel operations within the Kingdom, reinforcing Saudi Arabia’s ambitions to localize industrial technology and support Vision 2030 economic transformation goals.

SHERIDAN, WYOMING – May 11, 2025 – In a strategic move signaling the convergence of sustainable innovation and high-end design, Gentlebrand Design Agency has partnered with Zelda Water to introduce a game-changing concept in the mineral water sector: Zelda Smartweight Water. This new offering features a no-label bottle crafted entirely from BioPET—a 100% renewable, bio-based plastic—redefining eco-conscious packaging for the modern beverage industry.

With sustainability and visual impact at the core of the project, the Zelda bottle delivers an elevated aesthetic without compromising environmental values. Designed by Gentlebrand, the bottle merges elegance and performance, supporting beverage companies’ transition toward sustainable, circular packaging solutions while enhancing brand presence in the competitive Horeca and retail sectors.

Innovative Packaging Meets Circular Economy Goals

SHERIDAN, WYOMING – May 11, 2025 – At ProPak Asia 2025, Sidel is set to highlight its leadership in aseptic packaging and smart production technologies, showcasing cutting-edge solutions that drive operational efficiency, sustainability, and product safety for beverage and liquid food manufacturers across Southeast Asia.

From Booth AB06 in Hall 101, Sidel will demonstrate the transformative capabilities of its Aseptic Combi Predis™ system, a patented dry preform sterilisation solution for PET bottles. Alongside this flagship innovation, visitors will discover integrated line solutions, advanced quality control with IntelliADJUST™, and the Evo-ON® digital suite for real-time performance optimisation—each designed to meet the fast-evolving demands of modern production environments.

Leading the Way in Aseptic Packaging

SHERIDAN, WYOMING – May 11, 2025 – Sidel has unveiled the EvoFILL Can Compact, a compact, high-performance filling system engineered to meet the dynamic needs of premium beverage producers. Purpose-built for low-to-medium speed operations, this new solution is strategically designed to support flexibility, efficiency, and precision across a wide range of applications, from beer to carbonated soft drinks (CSDs), and even hot fill products.

As global beverage production surges—with alcoholic beverage volumes forecast to reach 492.1 billion units and non-alcoholic packaging expected to exceed 1.3 trillion units by 2028—demand for space-saving, multi-purpose filling solutions continues to grow. The EvoFILL Can Compact directly addresses this market need, offering a versatile, hygienic, and modular system for producers seeking to manage SKU complexity while maintaining operational excellence.

SHERIDAN, WYOMING – May 11, 2025 – Dentsply Sirona, in partnership with the American Association for Dental, Oral and Craniofacial Research (AADOCR), has officially announced the winners of the 2025 Student Competition for Advancing Dental Research and its Application (SCADA) Awards. Unveiled during the Opening Ceremonies of the 54th AADOCR Annual Meeting in New York, the awards spotlight student-led research poised to shape the future of oral healthcare innovation.

Highlighting Student Research Excellence in Dental Science

The SCADA Awards, a globally recognized platform for emerging dental researchers, continue to elevate promising talent within clinical, public health, basic, and translational science disciplines. This year’s winners were selected from top-tier dental schools across the United States and honored for their research addressing key challenges and advancements in dentistry.

SHERIDAN, WYOMING – May 9, 2025 – LivaNova PLC, a global leader in medical technology, announced strong first-quarter 2025 results today, demonstrating continued growth and operational efficiency. The company reported high single-digit revenue growth, including double-digit organic revenue increases, as well as expanding operating margins. LivaNova also raised its full-year 2025 revenue guidance, taking into account the impact of the SNIA environmental liability and current tariffs.

Strong Financial Performance in Q1 2025

For the first quarter of 2025, LivaNova recorded total revenue of $316.9 million, a 7.4% increase compared to the same period in 2024. On a constant-currency basis, revenue grew by 8.9%, with organic revenue expanding by 10.4%. Key drivers of growth included strong demand in the Cardiopulmonary and Neuromodulation segments, as well as increased sales from the Essenz™ Perfusion System and cardiopulmonary consumables.

SHERIDAN, WYOMING – May 9, 2025 – LivaNova PLC, a leading global medical technology company, has announced 12-month top-line data from its OSPREY clinical trial. The study demonstrates promising results for the aura6000™ System, an investigational device designed to treat moderate to severe obstructive sleep apnea (OSA). The data highlights sustained improvements in key health metrics, positioning the aura6000™ as a potential breakthrough in OSA management.

Strong Results from 12-month OSPREY Data

The OSPREY trial's 12-month data shows significant improvements for patients receiving the aura6000™ System, demonstrating the effectiveness of proximal hypoglossal nerve stimulation (p-HGNS) in managing OSA. The results confirm the system’s potential as a long-term solution for patients with moderate to severe cases who have previously struggled with conventional treatments.

Key highlights from the study include:

SHERIDAN, WYOMING – May 09, 2025 – Globus Medical, Inc. (NYSE: GMED), a leading provider of musculoskeletal solutions, has announced its financial results for the first quarter of 2025. The company reported worldwide net sales of $598.1 million, reflecting a 1.4% decrease year-over-year, primarily driven by a slowdown in Enabling Technology deal closures and temporary supply chain disruptions. Despite these challenges, Globus Medical saw notable growth in its core U.S. spine business and remains optimistic about its future prospects.